Rekvina Laboratories Limited adopted its audited financial statements for the fiscal year ended March 31, 2026, during its 38th Annual General Meeting (AGM) held on September 29, 2026.

The meeting, conducted via video conferencing in compliance with Ministry of Corporate Affairs guidelines, also saw the re-appointment of Mrs. Ilaben Pathak as a director retiring by rotation. Additionally, shareholders approved the appointment of Mr. Prateek Jain and Mr. Jay Chintan Patel as independent directors.

Meeting proceedings and governance updates

Mr. Surbhit Shah, Whole Time Director, welcomed members and confirmed the presence of quorum before declaring the meeting in order. The notice of the AGM, the statutory auditors' report on the financial statements, and the secretarial audit report were taken as read.

The agenda covered both ordinary and special business items. Under ordinary business, members considered the adoption of the audited financial statements for FY26 along with the Board of Directors' and Auditors' reports. Mrs. Ilaben Pathak, who retired by rotation and offered herself for re-appointment, was duly re-appointed.

Special business resolutions

Two key appointments were approved under special business to strengthen the board's independence:

1. Appointment of Mr. Prateek Jain as an Independent Director.
2. Appointment of Mr. Jay Chintan Patel as an Independent Director.

Mr. Prateek Jain served as the Chairman of the meeting. The AGM concluded at 2:45 pm after Mr. Surbhit Shah thanked the members for their participation.

Rekvina Laboratories Limited reported the resignation of its Managing Director, Amit Shah, with effect from September 11, 2026. The development was disclosed in a filing to the BSE following a board meeting held on September 23, 2026.

The company stated that Shah resigned citing personal reasons and personal commitments. The resignation was noted by the Board of Directors during their meeting, which commenced at 6:30 pm and concluded at 7:30 pm.

Leadership Change Details

The filing provided specific details regarding the departure of the Managing Director. The table below outlines the key particulars disclosed:

The disclosure confirmed that Shah held no directorships or committee memberships in other listed entities, nor were there any disclosed relationships between directors relevant to this appointment.

Registered Office Update

In addition to the leadership change, the Board approved a change in the company's registered office within the same city, effective September 23, 2026. The new address is located at 3rd Floor, 5 Laxmi Society, B/h Baroda Heart Institute, Near Haribhakti Colony, Old Padra Road, Vadodara – 390007.

The previous registered office was situated at 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Baroda. This administrative update was adopted alongside the acceptance of the Managing Director's resignation.